Covaxin found to be 77.8% effective against COVID-19: Lancet
Hyderabad: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin. As per phase-three clinical trials data,































